The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor
- 31 March 2011
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 18 (9) , 849-856
Abstract
Sleeping Beauty (SB3) transposon and transposase constitute a DNA plasmid system used for therapeutic human cell genetic engineering. Here we report a comparison of SB100X, a newly developed hyperactive SB transposase, to a previous generation SB11 transposase to achieve stable expression of a CD19-specific chimeric antigen receptor (CAR3) in primary human T cells. The electro-transfer of SB100X expressed from a DNA plasmid or as an introduced mRNA species had superior transposase activity in T cells based on the measurement of excision circles released after transposition and emergence of CAR expression on T cells selectively propagated upon CD19+ artificial antigen-presenting cells. Given that T cells modified with SB100X and SB11 integrate on average one copy of the CAR transposon in each T-cell genome, the improved transposition mediated by SB100X apparently leads to an augmented founder effect of electroporated T cells with durable integration of CAR. In aggregate, SB100X improves SB transposition in primary human T cells and can be titrated with an SB transposon plasmid to improve the generation of CD19-specific CAR+ T cells.Keywords
This publication has 27 references indexed in Scilit:
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptorBlood, 2010
- Comparative Analysis of Transposable Element Vector Systems in Human CellsMolecular Therapy, 2010
- piggyBac Transposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage MalignanciesHuman Gene Therapy, 2010
- A Transposon and Transposase System for Human ApplicationMolecular Therapy, 2010
- Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T LymphocytesJournal of Immunotherapy, 2009
- Stable gene transfer and expression in cord blood–derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon systemBlood, 2009
- Hybrid Lentivirus-transposon Vectors With a Random Integration Profile in Human CellsMolecular Therapy, 2009
- Sleeping Beauty Transposition From Nonintegrating LentivirusMolecular Therapy, 2009
- Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivityGene Therapy, 2009
- Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty SystemCancer Research, 2008